Article Sidebar
Views PDF: 203
Early results of laparoscopic lobectomy in the treatment of non-small cell lung cancer at Hanoi Medical University Hospital
Main Article Content
Abstract
Background: Lung cancer is the leading cause of cancer death in Vietnam. Total endoscopic lobectomy is indicated for the treatment of suitable stage non-small cell lung cancer. We conducted a study on patients undergoing laparoscopic lobectomy at Hanoi Medical University Hospital to evaluate the feasibility and safety of the surgery.
Methods: We conducted a study from January 2022 to December 2022 on 30 patients undergoing endoscopic lobectomy for non-small cell lung cancer at the Cardiovascular and Thoracic Surgery Unit, Hanoi Medical University Hospital.
Results: Most of the patients were in early stage, there were 4 patients with stage IIIA, the average operating time was 96 minutes, the average hospital stay was 5.7 days. . There was 01 death due to pulmonary embolism and 1 case of air leak > 7 days after surgery.
Conclusion: Total endoscopic lobectomy at Hanoi Medical University hospital shows feasibility and safety although there are still many problems to improve to improve the quality of treatment
Article Details
Keywords
Lung cancer, thoracoscopic surgery, lobectomy
References
2. A. Brunelli, A. Charloux, C.T. Bolliger. ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy). Eur Respir J. 2009;34:17–41.
3. Craig SR, Leaver HA, yap PL. Acute phase responses following minimal access and conventional thoracic surgery. Eur J Cardiothorac Surg. 2001;20:455–63.
4. Akinori Iwasaki. Results of videoassisted thoracic surgery for stage I/II non-small cell lung cancer. Eur J Cardiothorac Surg. 2004;26:158–64.
5. Omar Lababede, Moulay A. Meziane. The Eighth Edition of TNM Staging of Lung Cancer: Reference Chart and Diagrams. Oncologist. 2018;23(7):844–8.
6. Bộ Y tế Việt Nam. Chẩn đoán và điều trị ung thư phổi không tế bào nhỏ. Quy Trình Hướng Dẫn Điều Trị Các Bệnh Ung Thư. 2018;
7. Phạm Hữu Lư, Nguyễn Mạnh Hiệp. Cắt thuỳ phổi kèm nạo vét hạch điều trị ung thư phổi không tế bào nhỏ giai đoạn sớm bằng phẫu thuật nội soi lồng ngực một lỗ. Tạp Chí Học Việt Nam. 2022;513(2):291–4.
8. Trần Minh Bảo Luân, Nguyễn Hoài Nam. Đánh giá kết quả phẫu thuật cắt thùy phổi qua nội soi lồng ngực trong điều trị ung thư phổi. Phẫu Thuật Tim Mạch Và Lồng Ngực Việt Nam. 2018;23:97–103.
9. Thân Trọng Vũ. Đánh giá kết quả phẫu thuật cắt thùy phổi nội soi điều trị ung thư phổi không phải tế bào nhỏ tại bệnh viện Đà Nẵng. Phẫu Thuật Tim Mạch Và Lồng Ngực Việt Nam. 2018;23:59–64.
10. Dekel Shlomi, Gingy Ronen Balmor. Screening for lung cancer: time for large-scale screening by chest computed tomography. Eur Respir J. 2014;44:217–38.
11. Ana Casal-Mouriño, Alberto Ruano-Ravina, María Lorenzo-González. Epidemiology of stage III lung cancer: Frequency, diagnostic characteristics, and survival. Transl Lung Cancer Res. 2021;10(1):506–18.
12. David S Ettinger, Douglas E Wood, Dara L Aisner. Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2022;20(5):497–530.
13. Paul J. Grant, M. Todd Greene, Scott A. Flanders,. Assessing the Caprini Score for Risk Assessment of Venous Thromboembolism in Hospitalized Medical Patients. Am J Med. 2016;129(5):528–35.
14. Adam Lackey,, Jessica S. Donington. Surgical Management of Lung Cancer. Semin Interv Radiol. 2013;13(30):133–40.